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ABSTRACT 
BACKGROUND AND AIMS 
Endoscopic mucosal resection (EMR) of peri-appendiceal sessile laterally spreading lesions (PA-LSLs) 
is technically demanding due to poor endoscopic access to the appendiceal lumen and the thin 
colonic wall at the base of the cecum.  We aimed to assess the feasibility and safety of EMR for PA-
LSLs.   
METHODS 
Consecutive LSLs ≥20 mm and PA-LSLs ≥10 mm detected at 3 academic endoscopy centers from 
September 2008 until January 2017 were eligible.  Prospective patient, procedural, and lesion data 
were collected. PA-LSLs were compared with LSLs in other colonic locations.  
RESULTS 
Thirty-eight PA-LSLs were compared with 1721 LSLs.  Referral for surgery without an attempt at EMR 
was more likely with PA-LSLs (28.9% vs 5.1%, P < .001) and those that involved a greater percentage 
of the appendiceal orifice (AO) were less likely to be attempted (P = .038).  The majority (10/11) of 
PA-LSLs were not attempted due to deep extension into the appendiceal lumen; 2 of 11 of these 
surgical specimens contained invasive cancer. Once attempted, complete clearance of visible 
adenoma (92.6%[PA-LSL] versus 97.6%[LSL], p=.14), adverse events, and rates of adenoma 
recurrence did not vary significantly between PA-LSLs and LSLs.  Seven of 7 patients with prior 
appendicectomy achieved complete adenoma clearance.  There were no cases of post-EMR 
appendicitis. Twenty of 22 (91%) PA-LSLs eligible for surveillance avoided surgery to longest follow-
up. 
CONCLUSIONS 
EMR is a safe, effective and durable treatment for PA-LSLs when specific criteria are fulfilled.  If the 
distal margin of the PA-LSL within the appendiceal orifice cannot be visualized or more than 50% of 
the circumference of the orifice is involved, surgery should be considered. Clinicaltrials.gov 
(NTC01368289). 
 
BACKGROUND AND STUDY AIMS 
Endoscopic mucosal resection (EMR) of laterally spreading colonic lesions (LSLs) has gained 
widespread acceptance due to cost
1
 and morbidity
2
 advantages in comparison with surgery.  Most 
procedures are performed on an outpatient basis and in long-term follow-up >95% are cured
3
.  
However, endoscopic resection of lesions involving the appendiceal orifice (peri-appendiceal LSLs, 
PA-LSLs) is technically more challenging and such lesions are often managed surgically.  Reasons for 
this complexity are mainly anatomical; the appendix is a narrow blind-ended tube, which cannot be 
accessed endoscopically and the colonic wall in the cecum is the thinnest of the entire colon. In 
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addition, serrated and tubulovillous adenomas involving the appendix may be more aggressive than 
their counterparts throughout the rest of the colon4.  
PA-LSLs are relatively uncommon, and technical data regarding how to safely and effectively perform 
endoscopic resection of such lesions are sparse.  Recently an expert multicenter study from Japan
5
 
described the successful endoscopic submucosal dissection of 76 PA-LSL.  Only 40% of these lesions 
actually involved the appendiceal orifice (AO); however, and such experience with this technique is 
seldom available in Western centers.  
EMR is the current standard of care for the management of LSLs; however, the medical literature 
regarding EMR for PA-LSLs is limited to a report using “underwater” EMR 
6
.  It is currently unknown 
whether standard inject and resect EMR for PA-LSL is safe or effective or which lesion features 
predict success or failure.  The present study is a description of the technical aspects, outcomes, and 
safety for PA-LSL referred for EMR to 3 tertiary referral centers in Australia over an 8-year period.   
PATIENTS, MATERIAL AND METHODS 
Data were collected and analyzed within a multicenter, prospective observational cohort study of 
patients referred for EMR of LSLs performed at 3 academic, tertiary referral centers in Australia from 
September 2008 until January 2017.  Consecutive LSLs ≥20 mm and PA-LSLs ≥10 mm were eligible for 
inclusion. 
Demographic, lesion and procedural data was collected on all patients prospectively.  Adverse events 
were assessed at 2 weeks after the procedure by structured telephone interview with the patient. 
Surveillance examinations were scheduled at desired intervals of 4 to 6 months (first surveillance, 
SC1) and 18 months (second surveillance, SC2) after the index procedure. 
Definitions 
LSLs were defined as PA-LSLs when they involved, or were located within 5 mm of the appendiceal 
orifice (AO).  Circumference of involvement of the AO was recorded to the nearest 25%.  Deep 
extension into the AO was recorded if the distal margin of the lesion within the AO could not be 
visualized.   
An attempt at EMR was defined by first snare placement and resection of tissue.  Size of LSL was 
described relative to an open snare of known diameter. Complete snare excision described resection 
of LSL with no additional modality other than snare.  Technical success was defined as complete 
clearance of visible adenoma.  Duration of procedure described time from first submucosal injection 
to completed EMR.  Intraprocedural bleeding (IPB) was described if bleeding during the procedure 
required endoscopic control.  Deep injury to the colonic wall was recorded relative to the Sydney 
Classification of Deep Mural Injury
7
.  Delayed bleeding was recorded if the patient required 
admission to hospital or repeat intervention after they had left the endoscopy room.  Recurrence 
was described if there was endoscopic evidence of residual or recurrent adenoma at the EMR scar 
during surveillance colonoscopy.  Histologic recurrence described histologic evidence of recurrence 
at the EMR scar.  Late recurrence described recurrence after a previously negative surveillance 
examination. 
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Exclusions 
Multiple lesions in the same patient were excluded due to the possibility of correlated observations 
for a single patient.  Patients in the active arm of the Soft Coagulation for the prevention of Adenoma 
Recurrence, “SCAR” randomized trial (NCT01789749) were excluded because there is potential that 
their outcomes differ significantly from standard inject and resect endoscopic mucosal resection.  
Similarly patients who underwent snare tip soft coagulation to the lesion margin outside the SCAR 
study and patients undergoing 2-stage EMR were excluded. 
EMR Procedures 
Senior endoscopists with extensive EMR experience or senior endoscopy fellows under their direct 
supervision performed all procedures. A microprocessor-controlled electrosurgical generator (VIO 
300D; ERBE Elektromedizin, Tübingen, Germany)8 was used.  The submucosal injectate comprised of 
succinylated gelatin (Gelofusine; B. Braun Australia Pty Ltd, Bella Vista, Australia)9 with indigo 
carmine blue (80 mg/ 500 mL solution) and 1:10,000 epinephrine (1 mL/10-mL injection).  Methylene 
blue was substituted occasionally when indigo carmine blue was unavailable. Sedation was with a 
combination of midazolam, fentanyl and propofol.  
A standardized, previously described inject-and-resect technique10 was used for EMR of LSLs.  Each 
lesion was carefully assessed using high-definition white light and narrow-band imaging (NBI) 
[Olympus, Tokyo, Japan] to evaluate morphology and pit pattern.  For PA-LSL, an attempt was made 
to assess deep extension into the AO before endoscopic resection; if this was detected the patient 
was referred for surgery. 
Once a decision had been made to attempt the lesion, careful, small-volume injection of 
chromogelofusine was made so as not to occlude the appendiceal orifice and obscure visualization of 
the distal aspect of the lesion.  For resections around the AO, a 10-mm snare thin-wire snare was 
used (eg, Captivator II [Boston Scientific, Mass, USA] or TeleMed Hexagonal Snare [Telemed Systems, 
Mass, USA]) to maximize tissue capture.  Care was taken throughout the resection to ensure deep 
extension into the AO had not been revealed after removal of surrounding adenoma.  Small areas of 
residual adenomatous tissue that eluded snare capture were treated with argon plasma coagulation 
(before 2012) or forceps avulsion with adjuvant snare tip soft coagulation [ERBE Soft Coagulation, 
Effect 4, 80W] thereafter.  Examples of the EMR of PA-LSLs are shown in Figures 1, 2, and 3 and 
Video 1. 
After EMR patients were observed for 4 hours and discharged home if well; a clear fluid diet was 
recommended until the next morning. 
At SC1 and SC2, the EMR scar was located and it was assessed under high-definition white light and 
NBI according to our standardized scar assessment protocol
11
.  If there was suspicion for recurrent 
adenoma, this was removed with a snare or forceps avulsion with adjuvant snare tip soft coagulation 
and the margins of the resection site over the scar treated with snare tip soft coagulation.  If patients 
were referred for surgery, details of the surgical outcomes and the resection specimen were 
obtained from the relevant institution. 
Statistical Analysis 
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PA-LSL were compared with LSL.  Statistical analysis was performed using SPSS version 22 (IBM, 
Chicago, Ill) with 2-tailed t-test used for normally distributed continuous variables, Mann Whitney U 
test for skewed continuous variables and chi-squared test or the Fisher exact test for categorical 
variables.  Significance of P was regarded at p < .05.  
 
RESULTS 
A total of 2119 patients (2376 LSL) were recruited over the study period (Figure 4).  After exclusions, 
38 PA-LSLs and 1721 LSLs were included in the study.  The mean age of patients with PA-LSL was 68.1 
years (standard deviation [SD] 11.8) versus 67.7 years (SD 11.8, P=.82).  Thirteen of 38 (34.2%) in the 
PA-LSL group were male versus 905 of 1721 (52.6%, P=.025). Eight of 38 (21%) patients with PA-LSLs 
had undergone prior appendicectomy. 
LESION ASSESSMENT 
Median size of PA-LSLs was 13 mm (interquartile range [IQR] 20-30) and was smaller than LSLs , 
median size 35 mm (IQR 25-50, P < .001 ) [Table 1].   Lesion morphology and Kudo classification were 
broadly similar between PA-LSLs and LSLs. PA-LSLs were more commonly Paris classification 0-IIa 
(71.1%) than LSLs (48.4%), P =.06. 
Six of 38 (22%) PA-LSL did not involve the AO but were located within 5 mm thereof.  A further 8 
(21%) involved 25% of the AO circumference, 13 (34%) involved 50%, 2 (5%) involved 75% and 9 
(24%) involved 100% [Supplementary table 1].  Ten (32%) PA-LSLs extended deeply into the 
appendiceal lumen; in 2 of these cases this was not revealed until midway through the EMR 
procedure. 
EMR PROCEDURES 
EMR was attempted in 27 of 38 (71.1%) PA-LSLs versus 1634 of 1721 LSL (94.9%; p <.001).  Reasons 
for not attempting PA-LSLs were deep extension into the AO in 10 of 11 (91%) and concern for 
submucosal invasive cancer (SMIC) in 2 of 11 (18%).  Reasons for not attempting LSLs were concern 
for SMIC in 65 of 87 (75%) and technical reasons in the remainder.   
Submucosal fibrosis within the EMR defect was more common in PA-LSLs undergoing EMR (14/27, 
51.9%) versus LSL (405/1634, 24.8%, P < .001), and complete snare excision was lower in the PA-LSL 
group (18, 66.7%) versus the LSL group (1287, 78.8%, p=.13). Adjuvant modalities used to assist 
resection in the PA-LSL group were APC in 6 of 27 (22.2%) cases and forceps biopsy with adjuvant 
snare tip soft coagulation in 3 (11.1%).  Procedures were of similar median duration (23 vs 20 min, 
p=.319).  Technical success of EMR was not different between the PA-LSL group (25/27, 92.6%) and 
the LSL group (1595/1634, 97.6% P=.14).  Lesions achieving technical success in the PA-LSL group 
involved a smaller percentage of the AO (P=.038) and did not deeply involve the AO (P<.001).  Seven 
of 7 patients with a prior appendicectomy attempted for EMR achieved technical success [Table 2].  
The rates of intraprocedural bleeding (7, 25.9% [PA-LSL] vs 254, 15.5% [LSL], P=.18) and occurrence 
of deep injury to the colonic wall (P=.61) did not differ between the cohorts.  Histological type and 
dysplasia grade did not vary between the cohorts.  There was no SMIC in histological specimens after 
EMR of PA-LSL versus 116 of 1634 (7.1%) after EMR of LSL, P=.25. 
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POST PROCEDURAL ADVERSE EVENTS 
Three patients in the PA-LSL cohort were admitted overnight after the procedure.  One patient was 
admitted directly for significant pain with a normal CT scan, required supportive measures only and 
was discharged the next day.  The other 2 patients were admitted due to delayed bleeding; this 
occurred at a similar rate in the PA-LSL cohort (2/27, 7.4%) as the LSL cohort (93/1634, 7.1%, P=.67).  
There were no delayed perforations in the PA-LSL cohort versus 4 (0.2%) in the LSL cohort (p=1.000). 
FOLLOW-UP 
The outcomes of PA-LSL are summarized in Figure 4.  Twenty-two PA-LSL (22/22 (100%) due 
surveillance) underwent first follow-up (SC1) at median 5.7 months.  Recurrence was detected in 5 of 
22 (22.7%) and was treated endoscopically in 3 of 5 (60%) cases.  Two of 5 recurrences measured 
between 2 mm and 5 mm, 2 of 5 were between 5.1 and 10mm, and 1 of 5 was >10 mm.  Histologic 
confirmation of recurrence was available in 2 of 5 cases.  2 patients were referred for surgery due to 
inability to resect recurrence.  One of these patients,  having undergone a successful EMR of a 30 mm 
peri-appendiceal lesion, had attempted hot snare excision of a 5 mm recurrence at the edge of the 
EMR scar;  this led to a full-thickness perforation that could not be closed endoscopically.  The 
patient was referred for surgery and underwent emergency right hemicolectomy with no long-term 
adverse event.  In comparison LSL recurred with similar frequency (186/1263, 14.7%, P=.36).  One 
hundred sixty-nine (91%) were treated endoscopically and 17 (1.3%) required surgery due to inability 
to resect recurrence. 
Fourteen (/15 (93%) due surveillance) PA-LSL (underwent second follow-up (SC2) at median 18 
months after index EMR.  Recurrence was detected in 1 of 14 (7.1%) cases.  The previous surveillance 
procedure had been clear.  This recurrence was successfully treated endoscopically.  Of those PA-LSL 
undergoing surveillance colonoscopy 20 of 22 (91%) avoided surgery to longest follow-up.  In 
comparison 52 of 751 (6.9%) patients with LSL experienced recurrence (P=1.0), of which 29 (3.9%) 
were late recurrences (P=1.0).  Forty-nine of 52 (94%) were treated endoscopically, and 3 of 52 
required surgery. A total of 1243 of 1263 (98%) LSL and 20 of 22 (91%) PA-LSLs undergoing 
surveillance colonoscopy avoided surgery to longest follow-up. 
DETAILS OF PA-LSL REFERRED FOR SURGERY 
Thirteen of 38 (34%) patients with PA-LSLs were referred for surgery within 2 weeks of the index 
procedure, 11 without an attempt at EMR and 2 after technical failure of EMR [Supplementary Table 
2].   Although this was higher than LSL (237/1721, 13.8%), after EMR was attempted rates of surgery 
were similar between the cohorts (2/27, 7.4% [PA-LSL] versus 111/1634, 6.8% [LSL], P=.71).  Figure 5 
demonstrates examples of PA-LSL referred directly for surgery. 
Ten patients with a PA-LSL underwent laparoscopic right hemicolectomy and 3 patients laparoscopic 
caecectomy.  Two of 11 (18.2%) patients with endoscopic evidence of deep extension into the AO 
had evidence of invasive carcinoma in the surgical specimen.  No malignant histology was found in 
patients who achieved technical success at EMR.  One patient experienced significant wound 
haematoma and malunion of their abdominal wound after laparascopic caecectomy with a 
protracted inpatient stay.  Other surgical outcomes were successful and uneventful in terms of 
adverse events. 
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DISCUSSION 
Endoscopic mucosal resection is the standard of care for colorectal LSLs without evidence of 
submucosal invasive cancer.  We present a prospective cohort study of EMR of PA-LSLs in 
comparison to those in other colonic locations.  The results demonstrate that EMR is a safe and 
effective technique for the management of PA-LSLs.  Meticulous case selection is required.  If there is 
no endoscopic imaging evidence of SMIC and provided the distal margin of the lesion can be 
visualized within the appendiceal orifice, 91% of patients who underwent surveillance colonoscopy 
avoided surgery to a median of 18 months. 
Although there are few reports of standard EMR to remove PA-LSLs other techniques have been 
explored.  Binmoeller et al
6
 described the use of ‘Underwater EMR’ to remove 27 PA-LSLs involving 
the AO.  The distance from the AO was not defined although 22 of 27 were described as extending 
into the AO.  Median lesion size was 15 mm, significantly smaller than this study.  Technical success 
was 89% although the cohort from which these patients originate was not described, and therefore 
no comparator arm was provided.  In addition, although 91% of PA-LSLs underwent follow-up with 
residual adenoma in 10%, median follow-up was only 29 weeks.  One of the resected specimens 
contained invasive cancer and 2 of 27 patients experienced post-polypectomy syndrome, perhaps 
highlighting the difficulties of lesion and defect assessment underwater and without a chromic dye.   
Recently an expert multicenter study from Japan
5
 described the endoscopic submucosal dissection 
(ESD) of 76 PA-LSLs.  Although over 60% of the lesions (median size 49 mm) did not involve the AO 
(definition included up to 12 mm from AO), impressive rates of en bloc resection (94.7%) and R0 
resection (89.5%) were achieved.  Zero of 63 patients undergoing follow-up experienced recurrence.  
Such expertise, although admirable, is not available in the vast majority of Western centers.  In 
addition, the opportunity cost for this procedure (mean duration 91 minutes versus 20 minutes in 
this study) is high for benign disease (2/76 lesions had SMIC at histology, both had SM2 disease and 
underwent surgery).  Of note appendicitis was experienced in 2 of 76 patients in this study. 
A similarly contemporary study, while examining the feasibility of endoscopic full-thickness resection 
(EFTR) for colorectal LSLs
12
, included 5 cases of PA-LSL.  Two of 5 could not be successfully resected 
en bloc.  One-third that were resected had a positive peripheral margin of the specimen for 
adenoma.  Appendicitis was not observed in the 3 successful cases.  A further study described the 
use of EFTR to resect 4 PA-LSL 
13
.  Relationship to the AO was not discussed neither was PA-LSL 
specific rates of complete/R0 resection.   Appendicitis requiring laparascopic appendicectomy of the 
residual appendix was noted in 1 of the 4 cases. Despite these mediocre initial results and despite 
technical drawbacks of the device, the technique is conceptually appealing for this indication and 
further results are awaited. 
No other case series has addressed EMR of PA-LSLs using standard inject and resect EMR techniques.  
This is surprising because EMR is the standard of care for LSLs among Western endoscopists for 
predicted benign disease.  The present study records 38 PA-LSLs, which were assessed for EMR over 
an 8-year time period.  These lesions are uncommon (1% of our overall cohort).  Once an LSL involves 
the AO it is paramount to assess the degree of extension into the appendiceal lumen.  This can often 
be performed with a biopsy forceps, manipulating the LSL in an attempt to visualize the distal extent.  
In this series we did not perform EMR if the lesion extended beyond visualization within the AO.  This 
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approach is borne out by the surgical specimens from patients who had deep extension into the AO 
in which 2 of 12 (17%) specimens contained invasive cancer.  In 2 cases of deep extension, it was not 
possible to assess the degree of extension before resection, this only becoming clear midway 
through the resection.  These resections were terminated when the degree of extension became 
clear.  Neither of these specimens contained invasive cancer.   
PA-LSLs present the endoscopist with particular technical challenges.  Access to the base of the 
cecum is often difficult.  The colonic wall at the base of the cecum is thin; this necessitates precise 
direction of submucosal injection (tangential to the lesion) to prevent transmural injection and its 
attendant risks.  Submucosal fibrosis is common in this location (observed in over 50% of PA-LSLs in 
this study) and may hamper tissue capture.  For this reason we prefer a stiff, thin-wire snare in this 
location.  Adjuvant techniques such as cold avulsion with adjuvant snare tip soft coagulation were 
necessary in over 30% of cases. 
If the distal margin of the lesion within the AO can be visualized, PA-LSL EMR outcomes are very 
good.  Technical success of PA-LSLs (93%) was similar to LSLs (98%).  There was no difference in 
either intraprocedural or postprocedural adverse events. No resection specimens contained 
malignant histology.  Recurrence and surgery were not more common during surveillance than LSLs.  
The lack of appendicitis is perhaps surprising given that 14 of 20 (70%) of attempted PA-LSLs in this 
study without prior appendicectomy involved the AO.  We suggest that this reflects small-volume 
injection and careful snare placement during the procedures.  We also note that we have completed 
resections of LSL in patients with previous appendicectomy where the LSL completely encircles the 
prior AO.  Intense submucosal fibrosis is experienced in this situation but is technically possible 
[Figure 3].  Of two patients we have performed this procedure, both had recurrence successfully 
treated at surveillance. 
Given the advances in laparascopic surgery with techniques to remove part of the cecum and spare 
the ICV
14
, the data from this study will inform a careful discussion with the patient about which 
approach to take to the initial lesion.  In particular, the patient must understand that surveillance 
colonoscopy and treatment of recurrence is a necessary part of the endoscopic treatment of their 
lesion.  A suggested scheme for the management of PA-LSLs is given in Figure 5.  If the lesion does 
not fulfill the stated criteria for endoscopic resection, there is high likelihood that the lesion will 
eventually require surgery.  In this context it is hardly ethical or cost effective to attempt a resection 
that will commit the patient to endoscopic surveillance procedures if the risk of recurrence at those 
procedures or initial incomplete resection is so high that surgery will eventually be required.   
Limitations of this study include the small sample size of PA-LSLs. This is due to the rarity of these 
lesions. PA-LSLs are often small, and we included lesions ≥10 mm whereas LSLs included were ≥20 
mm; this may have provided an over stringent comparator arm and failed to highlight differences 
between PA-LSL and LSL.  There was high compliance to follow-up for PA-LSLs and LSLs at SC1, but 
this was lower at SC2.  If anything this likely biases toward worse reported outcomes at SC2 because 
we routinely followed-up patients with recurrence at the study center.  Despite these drawbacks the 
data were prospectively collected from three tertiary endoscopy centers, and the LSL cohort derives 
from the same centers allowing valid comparison. The lack of males in the PA-LSL cohort is of interest 
and deserves further attention; this was also the case in the study of Jacob et al. 
5
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In conclusion, EMR of PA-LSLs is a safe, effective and durable treatment but is technically challenging. 
PA-LSLs are less likely to be suitable for EMR than LSLs throughout the rest of the colon and careful 
assessment of the lesion at the index colonoscopy is essential.  If the distal margin of the LSL within 
the appendiceal lumen cannot be visualized surgery is the treatment modality of choice.  If the distal 
margin is visualized, EMR offers excellent outcomes that avoid the risks of surgery and in the vast 
majority of cases offers a cure for the patient.  
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TABLES 
 PA-LSL 
n=38 
LSL 
n=1721 
P 
Patient    
Age, mean (SD) 68.1 (11.8) 67.6 (11.8) .82 
Sex, Male, n(%) 13 (34.2) 905 (52.6) .025 
    
LSL    
Size, mm, IQR 25 (20-30) 35 (25-50) <.001 
Previous Attempt , 
n(%) 
3 (7.9) 215 (12.5) .62 
Morphology, n(%)    
Granular 24 (63.2) 919 (53.4) .42 
Non granular 11 (28.9) 497 (28.9)  
Mixed 2 (5.3) 124 (7.2)  
Unable to classify 1 (2.6) 181 (10.5)  
Paris, n(%)    
0-Is 5 (13.2) 321 (18.7) .06 
0-IIa 27 (71.1) 833 (48.4)  
0-IIa,Is 5 (13.2) 382 (22.2)  
Other (IIb, IIa+c etc) 1 (2.6) 185 (10.7)  
Kudo*, n(%)    
II 2 (5.3) 193 (11.8) .340 
III 10 (26.3) 500 (30.6)  
IV 25 (65.8) 832 (50.9)  
V 1 (2.6) 111 (6.8)  
Attempted EMR, n(%) 27 (71.1) 1634 (94.9) <.001 
    
 n=27 n=1634  
Procedure    
Submucosal Fibrosis, 
n(%) 
14 (51.9) 405 (24.8) <.001 
Duration, min, IQR 23 (14-68) 20 (10-30) .319 
Complete snare 
excision , n(%) 
18 (66.7) 1287 (78.8) .13 
Adjuvant technique (of 
remainder , n(%) 
   
APC 6 (22.2) 48 (2.9)  
Forceps biopsy and 
STSC 
3 (11.1) 299 (18.3)  
Technical success, n(%) 25 (92.6) 1595 (97.6) .14 
    
IPB, n(%) 7 (25.9) 254 (15.5) .18 
Deep Injury, n(%)    
II 2 (7.4) 55 (3.4) .61 
III 0 (0) 37 (2.3)  
IV 0 (0) 9 (0.6)  
V 0 (0) 2 (0.1)  
Histology, n(%)    
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TA 4 (14.8) 414 (25.3) .14 
TVA 17 (63.0) 945 (57.8)  
Serrated 5 (18.5) 267 (16.3)  
Other 1 (3.7) 8 (0.5)  
Dysplasia, n(%)    
None 4 (14.8) 186 (11.4) .23 
LGD 19 (70.4) 1021 (62.5)  
HGD 3 (11.1) 427 (26.1)  
Cancer, n(%) 0 (0) 116 (7.1) .25 
    
Post procedural AE    
Delayed bleeding, n(%) 2 (7.4) 93 (5.7) .67 
Delayed perforation, 
n(%) 
0 (0) 4 (0.2) 1.000 
    
Follow up    
Surgery by 2 weeks, 
n(%) 
2 (7.4) 111 (6.8) .71 
    
 n=22 n=1263  
Time to SC1 5.7 (4.9-6.8) 5.1 (4.0-6.9)  
Recurrence at SC1, 
n(%) 
5 (22.7) 186 (14.7) .36 
Histologic Recurrence 
at SC1, n(%) 
2/14 (14.3) 129/574 (22.5) .75 
Surgery at SC1, n(%) 2 (9.1) 17 (1.3) .40 
    
 n=14 n=751  
Time to SC2, n(%) 18.0 (16.0-21.5) 18 (14.9-22.5)  
Recurrence at SC2, 
n(%) 
1 (7.1) 52 (6.9) 1.0 
Late Recurrence at 
SC2, n(%) 
0 (0) 29 (3.9) 1.0 
Surgery at SC2, n(%) 0 (0) 3 (0.4) 1.0 
 
Table 1; Characteristics of PA-LSL versus LSL.  PA-LSL – peri-appendiceal LSL, LSL – laterally spreading 
lesion, SD – standard deviation, IQR – interquartile range, APC – argon plasma coagulation, STSC – 
snare tip soft coagulation, LGD – low grade dysplasia, HGD – high grade dysplasia, SC1 – surveillance 
colonoscopy 1, SC2 – surveillance colonoscopy 2.  *observations available in 1539 cases.  Recurrence 
denotes the endoscopic detection of recurrence at an EMR scar and histologic recurrence the 
histologic confirmation of recurrence.  
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 Not 
 Attempted 
n=11 
Attempted, 
failed 
n=2 
Successful 
EMR 
n=25 
 
Overall 
n=38 
P 
Size of LSL median 
(mm) 
20 (15-20) 28 (25-28) 25 (20-30) 25 (20-30) .034 
% involvement of 
AO, n (%) 
     
Within 5mm 0 0 6 (24) 6 (22) .038 
25% 1 (9) 0 7 (28) 8 (21) 
50% 3 (28) 2 (100) 8 (32) 13 (34) 
75% 2 (18) 0 0 2 (5) 
100% 5 (46) 0 4 (16) 9 (24) 
Deep extension 
into Appendiceal 
orifice, n (%) 
10 (91) 2 (100) 0 12 (32) <.001 
      
Prior 
Appendicectomy, n 
(%) 
1 (9.1) 0 (0) 7 (28) 8 (21.1) .498 
Appendicitis, n (%) x 0 (0) 0 (0) 0 (0) 1 
 
Table 2;  Specific characteristics of PA-LSL.  PA-LSL – periappendiceal LSL, LSL – laterally spreading 
lesion, AO – appendiceal orifice. 
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FIGURE LEGENDS 
Figure 1 – a) Half circumferential LSL at the base of the caecum extending to the appendiceal orifice.  
b) LSL seen to involve 50% of the appendiceal orifice. c-d) Sequential inject and resect endoscopic 
mucosal resection used to isolate the peri-appencieal component e).  f) Thin wire snare and cold 
forceps avulsion (white arrow) used to remove the portion of the LSL involving the appendiceal 
orifice.  g) Completed resection defect.  h) Appearances of the endoscopic resection scar at second 
surveillance examination (18 months after index) with no evidence of recurrence.  LSL – laterally 
spreading lesion. 
Figure 2 – a) Peri-appendiceal LSL involving 50% circumference of the appendiceal orifice.  b) Snare 
resection with margin of normal tissue. c) Snare resection is hampered by submucosal fibrosis. d-e) 
Standard biopsy forceps used to avulse residual non-lifting adenoma. f) Snare tip soft coagulation is 
applied to the avulsion bed.  g) Completed resection with complete removal of visible adenoma. e) 
Surveillance colonoscopy with a well-formed scar at the appendiceal orifice 6 months after the index 
procedure.   LSL – laterally spreading lesion. 
Figure 3 – EMR in patients with prior appendicectomy.  a,b) Fully circumferential PA-LSL at the AO in 
a patient with a previous appendicectomy.  c) Sequential inject and resect has been performed to 
completely resect the lesion.  d) At first surveillance colonoscopy a central focus of recurrent 
adenoma is seen overlying the EMR scar. e) Complete destruction of residual adenoma is achieved 
using a thin wire snare and coagulation current with snare tip soft coagulation applied to the 
surrounding scar.  f) 35mm Paris 0-IIa LSL overlying the prior AO in another patient with prior 
appendicectomy.   g+h) Sequential inject and resect EMR used to completely remove the lesion 
revealing underlying submucosal fibrosis at the site of the prior AO.  LSL – laterally spreading lesion, 
PA-LSL, periappendiceal laterally spreading lesion, EMR – endoscopic mucosal resection, AO – 
appendiceal orifice. 
Figure 4 – Flow of patients through the study comparing the outcomes of PA-LSL and LSL.  ER – 
endoscopic resection, LSL – laterally spreading lesion, PA-LSL – peri-appendiceal laterally spreading 
lesion, SMIC – submucosal invasive cancer, SC1 – first surveillance colonoscopy, SC2 – second 
surveillance colonoscopy, AO – appendiceal orifice, SCAR RCT – snare tip soft coagulation for the 
prevention of adenoma recurrence randomized controlled trial, duplicate – smaller lesions in the 
same patient * indicates percentage of patients undergoing SC1 that avoided surgery to this follow 
up.  Percentages rounded to the nearest whole number.  
Figure 5 – Examples of PA-LSL that were referred directly for surgery without an attempt at EMR.  a) 
Circumferential donut shaped LSL fully encircling the AO. b) A biopsy forceps is often useful to expose 
the orifice if there is doubt about deep extension. c) Large LSL at the base of the caecum seen to 
completely encircle the AO.  d-f) Further views highlight deep extension into the appendiceal lumen 
beyond the limit of visualization. 
Figure 6 – Suggested schema for the management of PA-LSL.  High risk features for SMIC include 
demarcated area of Kudo V pit pattern, NICE III or Sano IIIb morphology and Paris IIa+c morphology.  
SMIC – submucosal invasive cancer, AO – appendiceal orifice, EMR – endoscopic mucosal resection, 
LSL – laterally spreading elsion, PA-LSL – periappendiceal laterally spreading lesion. 
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Video 1 – Video demonstrating the technique of endoscopic mucosal resection of peri-appendiceal 
laterally spreading lesions. 
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SUPPLEMENTARY TABLES 
 Not involving AO 
n=6 
<= 50% AO involved 
n=21 
>50% AO involved 
n=11 
Patient    
Age, mean (SD) 73.7 (5.1) 67.9 (12.1) 65.4 (13.4) 
Sex, Male, n (%) 3 (50.0) 8 (38.1) 2 (18.2) 
    
LSL    
Size, mm, IQR 27.5 (20-30) 25 (15-32.5) 25 (20-35) 
Previous Attempt , n (%) 0 (0) 2 (9.5) 1 (9.1) 
Morphology, n (%)    
Granular 3 (50.0) 13 (61.9) 8 (72.7) 
Non granular 1 (16.7) 8 (38.1) 2 (18.2) 
Mixed 2 (33.3) 0 (0) 0 (0) 
Unable to classify 0 (0) 0 (0) 1 (9.1) 
Paris, n (%)    
0-Is 3 (50.0) 1 (4.8) 1 (9.1) 
0-IIa 3 (50.0) 16 (76.2) 8 (72.7) 
0-IIa,Is 0 (0) 4 (19.0) 1 (9.1) 
Other (IIb, IIa+c etc) 0 (0) 0 (0) 1 (9.1) 
Kudo*, n (%)    
II 0 (0) 1 (4.8) 1 (9.1) 
III 2 (33.3) 6 (28.6) 2 (18.2) 
IV 4 (66.7) 14 (66.7) 7 (63.6) 
V 0 (0) 0 (0) 1 (9.1) 
Attempted EMR, n (%) 6 (100) 17 (81.0) 4 (36.4) 
    
 n=6 n=17 n=4 
Procedure    
Submucosal Fibrosis, n(%) 3 (50.0) 9 (52.9) 2 (50.0) 
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Complete snare excision , n(%) 4 (66.7) 12 (70.6) 2 (50.0) 
Technical success, n(%) 6 (100) 15 (88.2) 4 (100) 
    
IPB, n(%) 1 (16.7) 4 (23.5) 2 (50.0) 
Histology, n (%)    
TA 1 (16.7) 3 (17.6) 0 (0) 
TVA 3 (50.0) 11 (64.7) 3 (75.0) 
Serrated 2 (33.3) 2 (11.8) 1 (25.0) 
Other 0 (0.0) 1 (5.9) 0 (0) 
Dysplasia, n (%)    
None 2 (33.3) 3 (17.6) 0 (0) 
LGD 4 (66.7) 11 (64.7) 4 (100) 
HGD 0 (0) 3 (17.6) 0 (0) 
Cancer, n (%) 0 (0) 0 (0) 0 (0) 
    
Post procedural AE    
Delayed bleeding, n(%) 0 (0) 1 (5.9) 1 (25.0) 
Delayed perforation, n(%) 0 (0) 0 (0) 0 (0) 
    
    
Follow up    
Surgery by 2 weeks, n (%) 0 (0) 2 (11.8) 0 (0) 
    
 n=6 n=12 n=4 
Recurrence at SC1, n (%) 3 (50.0) 1 (8.3) 1 (25.0) 
    
 n=3 n=9 n=2 
Recurrence at SC2, n (%) 0 (0) 1 (11.1) 0 (0) 
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Supplementary table 1 - Characteristics of PA-LSL split by percentage involvement of the appendiceal orifice.  PA-LSL – peri-appendiceal LSL, LSL – laterally 
spreading lesion, SD – standard deviation, IQR – interquartile range, APC – argon plasma coagulation, STSC – snare tip soft coagulation, LGD – low grade 
dysplasia, HGD – high grade dysplasia, SC1 – surveillance colonoscopy 1, SC2 – surveillance colonoscopy 2. 
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Patient PA-LSL Surgery 
Age 
(years) 
Prior 
Appendicectomy 
PA-LSL 
size 
(mm) 
EMR 
attempted? 
Reason for 
surgery 
%AO 
involve
d 
Paris Morpholog
y 
Typ
e 
Histology (Remnant) 
dysplasia 
(Remnant) malignancy 
46 No 60 No SMIC and 
Deep AO 
100 0-Is G RH * * * 
66 No 15 No SMIC 50 0-IIa G RH TVA HGD Yes 
73 No 20 No Deep AO  100 0-IIa NG RH TVA LGD No 
50 No 20 No Deep AO 100 0-IIa G C SSA None No 
71 No 15 No Deep AO 75 0-IIa NG RH TVA HGD Yes 
77 No 10 No Deep AO 25 0-IIa NG C SSA None No 
65 No 10 No Deep AO 50 0-IIa NG RH TVA  Yes 
77 No 15 No Deep AO 50 0-IIa NG RH TVA LGD No 
60 No 20 No Deep AO 100 0-IIa G RH SSA None No 
49 Yes 20 No Deep AO 100 0-IIb NG RH Tubular LGD No 
71 No 25 No Deep AO 75 0-IIa G RH SSA Focal HGD No 
            
60 No 25 Yes Deep AO 50 0-IIa NG RH TVA LGD No 
56 No 30 Yes Deep AO 50 0-
IIa/Is 
G C Tubular LGD No 
 
Supplementary Table 2; Detailed characteristics of lesions that underwent surgery which were not attempted or failed at the index 
EMR. Remnant describes the presence of dysplasia or malignancy in the surgical specimen.  EMR – endoscopic mucosal 
resection, PA-LSL – peri appendiceal laterally spreading lesion, C – caecectomy, RH – right hemicolectomy, ICV – ileo-caecal 
valve, G – granular, NG – non-granular, TVA – tubulovillous adenoma, S – serrated lesion, TA – tubular adenoma, time – timing 
within the lesion cohort (1 – first half, 2- second half), LGD – low grade dysplasia, HGD – high grade dysplasia, NL – non-lifting, 
SMIC – submucosal invasive cancer.  All described lesions involved the AO.  *In one case details of the surgical specimen are not 
available.  Deep AO – describes deep extension into the AO.  SMIC – describes suspicion for SMIC. 
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